Blackstone Life Sciences announces $455 million collaboration with Boston Scientific

BSX•2026-11-02

Blackstone Life Sciences announced a $455 million collaboration to co-fund development of Boston Scientific’s Vitalyst heart pump for patients with cardiogenic shock.

1. Development collaboration

Blackstone Life Sciences announced a $455 million collaboration with Boston Scientific to co-fund development of the Vitalyst heart pump for patients with cardiogenic shock.

Blackstone Life Sciences announces $455 million collaboration with Boston Scientific

1. Development collaboration

Related News

The Williams Companies files for mixed shelf offering, size not disclosed

TOP Ships announces $5 million private placement of convertible notes and warrants

CRISPR Therapeutics files initial beneficial ownership statement for Chief Technical Officer Sivakesava Sakhamuri

SAIC announces pricing of upsized $500 million senior notes offering

Oruka Therapeutics CEO Lawrence Otto Klein reports sale of $2.39 million in common shares